Home/Filings/4/0000950170-24-032237
4//SEC Filing

Pitt Justin D 4

Accession 0000950170-24-032237

CIK 0001108109other

Filed

Mar 14, 8:00 PM ET

Accepted

Mar 15, 4:31 PM ET

Size

19.5 KB

Accession

0000950170-24-032237

Insider Transaction Report

Form 4
Period: 2024-03-15
Pitt Justin D
Pres,Chief Legal&Admin Officer
Transactions
  • Disposition to Issuer

    Common Stock

    2024-03-155,00112,584 total(indirect: By Spouse)
Holdings
  • Performance Based Restricted

    Exercise: $0.00Common Stock (30,000 underlying)
    30,000
  • Stock Options (Right to Buy)

    Exercise: $8.81From: 2022-03-01Exp: 2031-02-28Common Stock (20,000 underlying)
    20,000
  • Stock Options (Right to Buy)

    Exercise: $6.15From: 2024-03-01Exp: 2033-02-28Common Stock (30,000 underlying)
    30,000
  • Performance Based Restricted

    Exercise: $0.00Common Stock (30,000 underlying)
    30,000
  • Common Stock

    208,116
  • Performance Based Restricted

    Exercise: $0.00Common Stock (30,000 underlying)
    30,000
  • Stock Options (Right to Buy)

    Exercise: $4.99From: 2020-03-01Exp: 2029-02-28Common Stock (5,000 underlying)
    5,000
  • Stock Options (Right to Buy)

    Exercise: $4.93From: 2021-03-01Exp: 2030-02-28Common Stock (20,000 underlying)
    20,000
  • Stock Options (Right to Buy)

    Exercise: $10.18From: 2023-03-01Exp: 2032-02-29Common Stock (30,000 underlying)
    30,000
  • Stock Options (Right to Buy)

    Exercise: $2.87From: 2025-03-01Exp: 2034-02-28Common Stock (30,000 underlying)
    30,000
Footnotes (5)
  • [F1]The Reporting Person's spouse is no longer employed by an affiliate of the Issuer. The remaining unvested portion of her prior awards of restricted stock was forfeited in conjunction with her ceasing to be employed by an affiate of the Issuer. The Reporting Person disclaims beneficial ownership of the securities of the Issuer owned by his spouse, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
  • [F2]The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period.
  • [F3]The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2023-2025 Performance Period.
  • [F4]The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2024 and 12/31/2026 (the "2024-2026 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2024-2026 Performance Period.
  • [F5]Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.

Documents

1 file

Issuer

COMMUNITY HEALTH SYSTEMS INC

CIK 0001108109

Entity typeother

Related Parties

1
  • filerCIK 0001900988

Filing Metadata

Form type
4
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 4:31 PM ET
Size
19.5 KB